RF
AZN icon

Roxbury Financial’s AstraZeneca AZN Stock Holding History

Roxbury Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6K Buy
+151
New +$28.4K 0.02% 237
2025
Q1 		– Sell
-86
Closed -$11.6K – 357
2024
Q4 		$11.6K Buy
+86
New +$12K 0.01% 291

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Roxbury Financial's AZN Position: Q2 2026 in Review

Roxbury Financial opened a new position in AstraZeneca (AZN) in Q2 2026: 151 shares worth $28.6K. The stake represents 0.02% of the portfolio and ranks #237 among its holdings. This is a return to the name: Roxbury Financial previously reported a position in AZN as recently as Q4 2024.

Roxbury Financial first reported a position in AZN in Q4 2024 and has held it in 2 quarters since. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Roxbury Financial held 151 shares of AstraZeneca worth $28.6K as of Q2 2026.
  • AstraZeneca was a new Roxbury Financial position in Q2 2026.
  • AstraZeneca made up 0.02% of Roxbury Financial's portfolio in Q2 2026, its #237 holding.
  • Roxbury Financial first reported a position in AstraZeneca in Q4 2024 and has held it in 2 quarters since.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Roxbury Financial's 13F filing for Q2 2026, filed 1 Jul 2026.